Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months
Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months: A Randomized Clinical Trial Protocol
Urinary tract infections are common in infants, but obtaining a reliable urine sample from babies younger than 6 months can be challenging. Bladder catheterization is a commonly used method for collecting urine, although it is an invasive procedure that may cause discomfort.
This randomized, controlled, open-label clinical trial will compare two methods of urine collection in infants younger than 6 months of age who are suspected of having a urinary tract infection and require a urine test. The study will be conducted at Toledo University Hospital in Spain.
Infants will be randomly assigned to one of two groups. The intervention group will undergo the Herreros technique, a non-invasive method that uses gentle tapping over the lower abdomen and circular massage of the lower back to stimulate spontaneous urination. The control group will undergo intermittent bladder catheterization to collect a urine sample.
The main objective is to compare the success of the two methods in obtaining a urine sample. Secondary objectives include comparing the time required to collect urine, sample contamination rates, pain or discomfort experienced by the infants, complications, costs, and parents' or legal guardians' satisfaction with the procedure.
The study aims to provide evidence on the effectiveness, safety, and cost-effectiveness of the Herreros technique compared with bladder catheterization in infants younger than 6 months.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Urinary tract infection (UTI) is a common bacterial infection in childhood. Obtaining reliable urine samples from infants who are not toilet-trained can be challenging. Bladder catheterization is an established method for urine collection, although it is invasive and may cause pain or discomfort. The Herreros urination stimulation technique is a non-invasive alternative based on physical stimulation of spontaneous urination.
This randomized, controlled, open-label clinical trial will be conducted at Toledo University Hospital, Castilla-La Mancha, Spain. The study will compare the Herreros urination stimulation technique with intermittent bladder catheterization for urine collection in infants with suspected UTI.
A minimum of 60 participants is planned, with 30 participants allocated to each study group. Sample size estimation was performed using the GRANMO program, considering expected urine collection success rates of 86% and 100% in the intervention and control groups, respectively, with a two-sided alpha level of 0.05 and statistical power greater than 80%.
Participants will be randomly assigned in a 1:1 ratio using a computer-generated randomization sequence managed by an independent unit coordinator. Due to the nature of the procedures, blinding of healthcare professionals performing the interventions will not be possible. However, laboratory personnel responsible for urine culture analysis and sample contamination assessment will be blinded to group allocation.
Intervention procedures
In the intervention group, urine collection will be attempted using the Herreros technique. The procedure involves feeding the infant approximately 20-30 minutes before the intervention, cleaning the genital area, and alternating gentle suprapubic tapping with circular massage of the lumbar paravertebral region using the thumbs. These maneuvers will be performed for a maximum of five minutes or until spontaneous urination occurs. A midstream urine sample will then be collected in a sterile container.
Non-pharmacological analgesia, including non-nutritive sucking or 2% sucrose solution, may be used in accordance with the study protocol. If urine collection is unsuccessful within five minutes, bladder catheterization will be performed to obtain the required sample, and this circumstance will be documented.
In the control group, urine samples will be obtained through intermittent bladder catheterization performed by qualified healthcare professionals in accordance with the hospital's standard clinical procedures. The time required to complete the procedure will be recorded using a stopwatch.
Data collection and statistical analysis
Study data will be recorded using a standardized data collection form. Statistical analyses will be performed using IBM SPSS Statistics. Categorical data will be expressed as frequencies and percentages, while quantitative data will be summarized using means and standard deviations or appropriate alternative descriptive statistics.
Between-group comparisons will be performed using the chi-square test or Fisher's exact test for categorical variables and Student's t-test or Mann-Whitney U test for quantitative variables, depending on data distribution. Pearson or Spearman correlation analyses and multiple logistic regression will be used, where appropriate, to explore associations between relevant study variables.
Safety monitoring and ethical considerations
Participants will be monitored by the healthcare professionals performing the urine collection procedures. Any complications or adverse events potentially related to either technique will be documented, and appropriate clinical care will be provided. Serious adverse events will be reported to the unit coordinator and principal investigator within 24 hours.
The study will commence only after approval by the relevant Research Ethics Committee and authorization from the participating hospital services. Written informed consent will be obtained from parents or legal guardians before participation. All study data will be handled confidentially in accordance with applicable Spanish data protection legislation and ethical principles governing biomedical research.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: FRANCISCO JAVIER GÓMEZ MANZANO Principal Investigator, BSc
- Número de teléfono: +34653782821
- Correo electrónico: javier.gomezmanzano@uclm.es
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Infants of both sexes under 6 months of age (up to 180 days).
- Infants requiring a urine sample collection for the diagnosis of a suspected urinary tract infection (UTI) prescribed by a physician in the neonatology, pediatrics, or pediatric emergency department.
- Parents or legal guardians willing and able to sign the informed consent form.
Exclusion Criteria:
- Infants with prior antibiotic treatment.
- Infants with a diagnosis of urological or gynecological congenital malformations, severe phimosis, tight labial adhesions in females, genital infection, or complex genital abnormalities.
- Infants presenting with any skin lesion (such as wounds, burns, trauma, etc.) that could contraindicate or prevent the performance of the Herreros technique and/or urinary catheterization.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Diagnóstico
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Herreros Bladder Stimulation Group
Infants undergo the non-invasive bladder stimulation technique described by Herreros et al., combining feeding with gentle suprapubic taps and lumbar paravertebral massage to induce spontaneous midstream urine collection. |
Infants receive the non-invasive bladder stimulation technique described by Herreros et al. This involves a feeding (breast milk or formula) 20 to 30 minutes prior to the procedure, followed by a maximum of 5 minutes of alternating cycles of gentle suprapubic tapping (using fingertips) and lumbar paravertebral massage (using circular thumb movements). Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is administered during the procedure.
Otros nombres:
|
|
Comparador activo: Urinary Catheterization Group
Infants undergo intermittent urinary catheterization as the reference standard procedure for obtaining a sterile urine sample. |
Infants undergo intermittent urinary catheterization as the reference standard procedure. After proper perineal cleansing and the application of sterile lubricant, a pediatric urinary catheter (size 6-8 Fr) is gently inserted through the urethra into the bladder to obtain a sterile urine sample. Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is provided during the procedure.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Successful urine sample collection rate
Periodo de tiempo: Within 5 minutes (300 seconds) from the start of the procedure
|
Percentage of infants in each group in whom a sufficient urine sample for urinalysis and urocultivo is successfully obtained within 5 minutes after the start of the procedure. |
Within 5 minutes (300 seconds) from the start of the procedure
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time to urine collection
Periodo de tiempo: From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).
|
The total time elapsed (in seconds) from the start of the procedure until the successful collection of the urine sample. |
From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).
|
|
Urine sample contamination rate
Periodo de tiempo: From urine collection until the final urine culture report, assessed up to 72 hours
|
Percentage of collected urine samples classified as contaminated based on urocultive criteria (such as growth of two or more microorganisms, presence of non-uropathogens, or leukocyturia). |
From urine collection until the final urine culture report, assessed up to 72 hours
|
|
Parental satisfaction score
Periodo de tiempo: Immediately after the procedure, before discharge
|
Evaluation of parents' or legal guardians' satisfaction with the procedure, measured using an ad-hoc survey on a scale. PARENT/GUARDIAN OPINION AND SATISFACTION QUESTIONNAIRE FOR THE INFANT. The minimum score is 0, indicating the worst possible outcome, in which parents/legal guardians are not at all satisfied with the procedure performed on their infant or with the time required to obtain the urine sample. The maximum score is 10, indicating that parents/legal guardians are very satisfied with both the procedure performed and the time required to obtain the urine sample. |
Immediately after the procedure, before discharge
|
|
Procedure costs
Periodo de tiempo: During the urine collection procedure (including rescue catheterization, if needed)
|
Direct economic cost of each procedure based on material resources utilized and healthcare personnel time required per successful sample obtained. |
During the urine collection procedure (including rescue catheterization, if needed)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades urogenitales masculinas
- Enfermedades urológicas
- Enfermedades urogenitales femeninas
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Infecciones
- Infecciones del tracto urinario
- Técnicas de investigación
- Terapéutica
- Técnicas y procedimientos de diagnóstico
- Diagnóstico
- Cateterismo
- Técnicas de diagnóstico, urológicos
- Cateterización Urinaria
Otros números de identificación del estudio
Otros números de identificación del estudio
- 2295
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .